Revium Rx RVRC
OTC RVRC
$1.43 +0.00 (+0.00%)
At close: Oct 19, 2026 · 4:00 PM EDT

Revium Rx (RVRC) Common Equity (2024 - 2026)

Updated

Revium Rx's Common Equity was $5.52 million in Q2 2026.

Analysis

Revium Rx (RVRC) Common Equity (2024 - 2026) Analysis & Trends

At the end of FY2025, Common Equity at Revium Rx came in at $6.88 million, down 65.1% from FY2024.

  • In earlier years, Common Equity was $19.71 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 33.88 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 84.97 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -5.94 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 41.98 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 41.95 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 50.37 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 11.69 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 11.83 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 85.49 Bn
10 Revium Rx 86.84 Mn 86.00 Mn - 5.52 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.52 Mn
Dec 31, 2025 6.88 Mn
Jun 30, 2025 18.53 Mn
Dec 31, 2024 19.71 Mn
API Access

Revium Rx Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=RVRC&period=max&api_key=YOUR_API_KEY